6.5Overall
BLUE MARBLE HEALTH

Blue Marble Health

ConditionalScored Nov 2026

Blue Marble Health develops Health in Motion, a remote therapeutic monitoring platform that clinicians use to assign home rehabilitation and self-management programs and track patient progress.

bluemarblehealthco.com

Best for

  • Clinicians building a home pulmonary rehabilitation or RTM program
  • Research teams evaluating digital rehabilitation and self-management

Not ideal for

  • Patients seeking a ready-to-enroll national pulmonary rehabilitation clinic
  • Organizations without clinical staff to supervise rehabilitation
Blue Marble Health homepage or product landing page

Bottom line

Blue Marble Health is a conditional choice for clinicians building their own home rehabilitation service. Health in Motion offers program content and monitoring tools, but a buyer still needs the staff, clinical protocols, and reimbursement arrangements to deliver care.

Score breakdown

6.6
Condition-specific evidence
7.1
Home programs and monitoring
6.2
Clinical delivery requirements
5.4
Pricing clarity

Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.

Blue Marble Health’s buyer is a clinician or organization that wants software for home rehabilitation and remote therapeutic monitoring. Its pulmonary program overlaps with the care need addressed by Kivo Health, but the delivery models differ: Kivo supplies a clinical service, while Blue Marble supplies tools clinicians can use to deliver one.

The relevant cost comparison includes software plus the buyer’s own clinical labor and operating work. Blue Marble should not be presented as a turnkey replacement for a staffed pulmonary rehabilitation program. A clinic comparing those approaches is also deciding who will provide care and follow patients.

  • Condition-specific evidence (6.6): Small feasibility studies support usability, with limited evidence of broad clinical impact.
  • Home programs and monitoring (7.1): The platform includes home programs and a clinician monitoring portal.
  • Clinical delivery requirements (6.2): The buyer needs clinical staff and a delivery model; software alone is insufficient.
  • Pricing clarity (5.4): No standard public license or implementation price is supplied.

Health in Motion and Pulmonary Rehabilitation

The platform lets clinicians personalize home programs and review patient-reported progress. Its research page describes an eight-week virtual pulmonary rehabilitation program for people with COPD, evaluated against clinic-based care in a completed non-randomized study with 36 participants.

That is useful feasibility evidence, but a small study does not establish equivalence across all pulmonary rehabilitation settings. The same research page discusses stronger evidence for home rehabilitation in general. Those external studies should not be mistaken for trials of Blue Marble’s own software.

Blue Marble Health product details

Other Modules and Clinical Responsibilities

Health in Motion also includes fall-prevention and joint-rehabilitation content. Blue Marble’s BREATHE module covers asthma education and self-management, with exercise tracking, questionnaires, an action plan, and a clinician dashboard. These modules address different conditions and should be assessed separately.

In March 2026 Allergy & Asthma Network reported a two-week BREATHE feasibility and usability pilot. The announcement describes good usability and plans for a clinical trial; it does not show that the app improves asthma outcomes. A clinician adopting the platform still needs an assessment process, safe exercise prescriptions, escalation rules, and a way to respond when a patient deteriorates.

Blue Marble Health source

LeadIQ estimates Blue Marble Health annual revenue at $1 million to $10 million. Revenue source

What leaders say

What people like

"I can assign a home program and see the progress my patient reports."

"The pulmonary module gives us a structure for delivering rehabilitation at home."

What people don't like

"We still need our own clinicians to run the rehabilitation service."

Where customer reviews couldn't be found, our analysts attempted to give a voice to buyer sentiment, drawing on real information from review sites, forums and product documentation.

Based on: Blue Marble Health product page, Blue Marble Health supporting source.

Competitor landscape

Blue Marble Health supplies software for clinician-led rehabilitation. Kivo Health supplies staffed virtual pulmonary rehabilitation. They address a related care need, but adopting Blue Marble also requires a clinical delivery team. Kivo is therefore a service-model comparison, not a software replacement plotted here.

Pricing

ItemDetail
PlatformCommercial license and implementation terms require a quote.
Clinical deliveryBudget separately for assessment, supervision, follow-up, and escalation.
RTMTime tracking and billing support do not guarantee that a particular service will be reimbursed.
ComparisonCompare the total cost of operating a clinician-led program with purchasing a staffed service.

Recent news

  • September 2026: The National Council on Aging described Health in Motion’s digital fall-prevention program and its approval for implementation with Older Americans Act Title III-D funding. This concerns fall prevention, not pulmonary rehabilitation. Source
  • March 2026: Allergy & Asthma Network reported publication of BREATHE development and usability research. The announcement said a clinical trial would test health outcomes. Source
Methodology
WeightFactorWhat it measures
35%Customer outcomesWhether buyers get measurable operational or clinical-workflow results after go-live
30%ProductCapability depth, reliability, and fit for the job the category buys
20%ImplementationHow hard it is to stand up, integrate, train, and stabilize
15%Pricing clarityWhether a buyer can model total cost without a mystery quote
LabelMeaning
Highly recommendStrong outcomes and product with manageable caveats
RecommendSolid fit for the right buyer; know the tradeoffs
ConditionalOnly with a specific use case or heavy caveats
Not recommendedAvoid for most buyers in this category

Read our full methodology for how we weight scores and assign recommend labels.